Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MYC binding protein 2 pseudogene (ENSG00000249486) is a processed or unprocessed pseudogene related to the protein-coding gene "MYC binding protein 2" (MYCBP2, also known as PAM or E3 ubiquitin protein ligase)[4][5]. Pseudogenes like this are characterized by sequence similarity to protein-coding genes but contain mutations or other defects (such as stop codons or frameshifts) that prevent them from producing functional proteins[5][1][3]. While some pseudogenes can influence gene expression in rare instances (such as through competing endogenous RNA mechanisms), there is no evidence that this pseudogene acts as a functional gene or therapeutic target[5][3][1]. Clarification: - The functional gene MYCBP2 is an E3 ubiquitin ligase involved in axon guidance, synapse formation, and protein degradation by ubiquitination[4]. - The pseudogene form, i.e., "MYC binding protein 2 pseudogene" (ENSG00000249486), does not encode a functional protein and is not associated with known biological activities, disease mechanisms, or pharmacological targeting[5][1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MYC binding protein 2 pseudogene.